1. Tumor PD-L1 status and CD8+ tumor-infiltrating T cells: markers of improved prognosis in oropharyngeal cancer
- Author
-
Liesbeth Ferdinande, Sandrine Aspeslagh, Sylvie Rottey, Philippe Deron, Fréderic Duprez, Jo Van Dorpe, Tijl Vermassen, Astrid De Meulenaere, Debby Laukens, and Medical Oncology
- Subjects
EXPRESSION ,PD-L1 ,0301 basic medicine ,Oncology ,HPV ,medicine.medical_specialty ,Pathology ,CARCINOMA ,T cell ,TONSILLAR CANCER ,IMMUNE RESISTANCE ,ACTIVATION ,03 medical and health sciences ,0302 clinical medicine ,NECK-CANCER ,Internal medicine ,Medicine and Health Sciences ,Carcinoma ,medicine ,HEAD ,tumor infiltrating ,biology ,Proportional hazards model ,business.industry ,Tumor-infiltrating lymphocytes ,HUMAN-PAPILLOMAVIRUS ,Hazard ratio ,Biology and Life Sciences ,Cancer ,ASSOCIATION ,medicine.disease ,030104 developmental biology ,medicine.anatomical_structure ,tumor infiltrating lymphocytes ,030220 oncology & carcinogenesis ,biology.protein ,biomarker ,oropharynx ,business ,CD8 ,Research Paper - Abstract
// Astrid De Meulenaere 1, * , Tijl Vermassen 1 , Sandrine Aspeslagh 2 , Philippe Deron 3 , Frederic Duprez 4 , Debby Laukens 5 , Jo Van Dorpe 6 , Liesbeth Ferdinande 6, * and Sylvie Rottey 1, * 1 Department of Medical Oncology, Ghent University Hospital, 9000 Ghent, Belgium 2 DITEP, Gustave Roussy Cancer Centre, 94800 Villejuif, France 3 Department of Head, Neck and Maxillo-Facial Surgery, Ghent University Hospital, 9000 Ghent, Belgium 4 Department of Radiation Oncology, Ghent University Hospital, 9000 Ghent, Belgium 5 Department of Internal Medicine, Ghent University Hospital, 9000 Ghent, Belgium 6 Department of Pathology, Ghent University Hospital, 9000 Ghent, Belgium * These authors are senior authors Correspondence to: Astrid De Meulenaere, email: astrid.demeulenaere@ugent.be Keywords: oropharynx, HPV, PD-L1, tumor infiltrating lymphocytes, biomarker Received: March 06, 2017 Accepted: June 20, 2017 Published: July 06, 2017 ABSTRACT Introduction: The aim of this study was to evaluate the expression of PD-L1 in oropharyngeal squamous cell carcinoma. Its relation with clinicopathological variables, tumor infiltrating lymphocytes and survival was also determined. Results: Positive PD-L1 status for the SP142 clone related with improved overall survival in oropharyngeal squamous cell carcinoma. Tumors heavily infiltrated by tumor infiltrating lymphocytes were also linked with better outcome, and this as well for the total number of tumor infiltrating lymphocytes as for the CD3 + and CD8 + T cell count. A Cox proportional hazard model proved that solely infiltrating CD8 + T cells exhibit a positive effect on overall survival (hazard ratio = 0.31 [0.14–0.70]; P = 0.0050) Materials and Methods: Formalin-fixed, paraffin-embedded tissue from oropharyngeal tumors of 99 patients was immunohistochemically stained for PD-L1 (SP142 and 22C3 clones), CD3, CD8 and FoxP3. Expression of PD-L1, CD3, CD8, FoxP3 and HPV status were correlated with clinicopathological variables. Overall survival was determined by a log-rank (Mantel–Cox) test whereas the Cox proportional hazard model was used for multivariate analysis. Conclusions: Our results demonstrate that CD8 + T lymphocytes constitute an independent prognostic marker in patients diagnosed with oropharyngeal squamous cell carcinoma. PD-L1 positivity for SP142, but not for 22C3, also tends to have a positive effect on survival in oropharyngeal squamous cell carcinoma.
- Published
- 2017
- Full Text
- View/download PDF